Haemophilus influenzae type a (Hia) glycoconjugate vaccine clinical trials

A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine

Researchers are testing a new vaccine for a serious infection called Haemophilus influenzae serotype a (Hia). This first study in adults aims to check if the vaccine is safe and if it helps the body build protection against the Hia bacteria. It's hoped this could eventually protect children, especially those in Indigenous communities.